Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05325437
Other study ID # YZUC-007
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 1, 2022
Est. completion date October 1, 2024

Study information

Verified date December 2023
Source Northern Jiangsu People's Hospital
Contact Guo-Qing Jiang, MD
Phone +8651487373272
Email jgqing2003@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, the investigators compared the improvement of liver reserve function related indicators in patients with liver cirrhosis after laparoscopic splenectomy and azygoportal disconnection. To determine whether surgical treatment can help enhance postoperative liver reserve function and improve patient prognosis.


Description:

The patients were enrolled according to the research criteria, and collected the general basic information of the patients. After the preoperative preparation was perfected, the same surgical team performed laparoscopic splenectomy and azygoportal disconnection, and the same nursing team performed the nursing after the operation. Then, patients received a unified treatment plan after surgery, including medication, other treatments and follow-up. During the treatment, the liver reserve function related indicators of the patients were monitored before surgery, 3, 6, 12 and 24 months after surgery, including TBIL, DBIL, ALB, ALT, INR, PT, Child-Pugh, ascites, prealbumin, ICG-K, ICG-R 15 and ICG-T/2.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date October 1, 2024
Est. primary completion date October 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - A clinical, radiological or histologic diagnosis of cirrhosis of any etiology - Splenomegaly with secondary hypersplenism - gastroesophageal variceal bleeding - Informed consent to participate in the study Exclusion Criteria: - Hepatocellular carcinoma or any other malignancy, - Child-Pugh grade C - Recent peptic ulcer disease - History of Hemorrhagic stroke - Pregnancy. - Uncontrolled Hypertension - Human immunodeficiency virus (HIV) infection

Study Design


Intervention

Procedure:
Laparoscopic splenectomy and azygoportal disconnection
The laparoscopic splenectomy and azygoportal disconnection was performed by the same surgical team.

Locations

Country Name City State
China Clinical Medical College of Yangzhou University Yangzhou Jiangsu

Sponsors (1)

Lead Sponsor Collaborator
Northern Jiangsu People's Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Liver reserve function ICG-K at 3 months after surgery. The level of liver reserve function ICG-K at 3 months after surgery. 3 months
Primary Liver reserve function ICG-K at 6 months after surgery. The level of liver reserve function ICG-K at 6 months after surgery. 6 months
Primary Liver reserve function ICG-K at 12 months after surgery. The level of liver reserve function ICG-K at 12 months after surgery. 12 months
Primary Liver reserve function ICG-K at 24 months after surgery. The level of liver reserve function ICG-K at 24 months after surgery. 24 months
Primary Liver reserve function ICG-R 15 at 3 months after surgery. The level of liver reserve function ICG-R 15 at 3 months after surgery. 3 months
Primary Liver reserve function ICG-R 15 at 6 months after surgery. The level of liver reserve function ICG-R 15 at 6 months after surgery. 6 months
Primary Liver reserve function ICG-R 15 at 12 months after surgery. The level of liver reserve function ICG-R 15 at 12 months after surgery. 12 months
Primary Liver reserve function ICG-R 15 at 24 months after surgery. The level of liver reserve function ICG-R 15 at 24 months after surgery. 24 months
Primary Liver reserve function ICG-T/2 at 3 months after surgery. The level of liver reserve function ICG-T/2 at 3 months after surgery. 3 months
Primary Liver reserve function ICG-T/2 at 6 months after surgery. The level of liver reserve function ICG-T/2 at 6 months after surgery. 6 months
Primary Liver reserve function ICG-T/2 at 12 months after surgery. The level of liver reserve function ICG-T/2 at 12 months after surgery. 12 months
Primary Liver reserve function ICG-T/2 at 24 months after surgery. The level of liver reserve function ICG-T/2 at 24 months after surgery. 24 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05052892 - A Novel Spleen-dedicated Stiffness Measured by FibroScan to Evaluate Cirrhotic Portal Hypertension (CHESS2105)
Recruiting NCT05251272 - A Combined Model Based on Spleen Stiffness, Liver Stiffness and Platelets for Assessing Portal Hypertension in Compensated Cirrhosis (CHESS2202)
Recruiting NCT05928624 - A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients N/A
Recruiting NCT04578301 - Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease
Not yet recruiting NCT05515861 - Evaluation of EUS in Preventing Rebleeding After Endoscopic Cyanoacrylate Injection for Gastric Varices N/A
Recruiting NCT02364297 - TIPS in Fundal Variceal Bleeding (the TFB Study) N/A
Recruiting NCT01358123 - Value of Von Willebrand Factor in Portal Hypertension N/A
Completed NCT00493480 - Danish Carvedilol Study in Portal Hypertension Phase 3
Recruiting NCT06266260 - Evaluation of the Performance of Direct Portal Pressure Measurement by Endoscopic Ultrasound in a Large Cohort of Patients With Advanced Chronic Liver Disease of Different Etiologies and Newly Diagnosed Clinically Significant Portal Hypertension (EVADIPP)
Recruiting NCT03277651 - Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension N/A
Active, not recruiting NCT03736265 - Carvedilol for Prevention of Esophageal Varices Progression N/A
Completed NCT03451149 - Feasibility And Safety Of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Using A Radiofrequency Guidewire N/A
Completed NCT02994485 - Evaluation Of The Portal Pressure By Doppler Ultrasound In Cirrhotic Patients Before And After Simvastatin Phase 4
Completed NCT01923064 - Injection of Cyanoacrylate+Lipiodol vs Cyanoacrylate+Lauromacrogol in Gastric Varices N/A
Completed NCT01851252 - MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy Phase 1
Completed NCT01456286 - Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension Phase 2/Phase 3
Completed NCT01551966 - Esophageal Capsule Endoscopy in Children N/A
Completed NCT02344719 - Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis Phase 4
Recruiting NCT00414713 - Transfusion Requirements in Gastrointestinal (GI) Bleeding Phase 4
Completed NCT00766805 - Endoscopic Variceal Ligation (EVL)+ Drugs Versus Endoscopic Variceal Ligation (EVL) Alone For Secondary Prophylaxis N/A